Company: SHPH
Filing Date: 2025-11-17
Form Type: 8-K
Source: 0001493152-25-023845
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-11-17
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item      Notice                                                                                         

Shuttle
Pharmaceuticals Holdings, Inc. (the “ Company”) reported stockholders’ equity of $1,394,161 in its Quarterly Report
on Form 10-Q for the fiscal quarter ended September 30, 2025, and, as a result, was not in compliance with Nasdaq Listing Rule 5550(b)(1),
which requires companies listed on the Nasdaq Capital Market (“ Nasdaq”) to maintain a minimum of $2,500,000 in stockholders’
equity for continued listing (the “ Stockholders’ Equity Requirement”). The
Company believes that, as of the date of this Current Report on Form 8-K (this “ Form 8-K”), it has regained compliance with
the Stockholders’ Equity Requirement based upon the Company’s private placement consummated on November 4, 2025, pursuant
to which the Company raised aggregate gross proceeds of approximately $2.5 million, before deducting placement agent fees and offering
expenses payable by the Company. The Nasdaq Listing Qualifications staff the Stockholders’ Equity Requirement

Cautionary
Statement Regarding Forward-Looking Statements